MTPConnect’s focus is taking cutting-edge research from bench to bedside by working collaboratively with all parts of Australia’s medical technology, biotechnology and pharmaceutical sector; from universities and medical research institutes to start-ups and small to medium sized enterprises and governments, policy makers and regulators.
MTPConnect designs and delivers accelerator, sector building and workforce programs for Australian Government agencies and state governments. It co-funds cutting edge innovation and research projects, supports expansion of the clinical trials ecosystem, develops workforce commercialisation skills and represents the Australian sector with a strong and independent voice to streamline regulation pathways and promote the best interests of the entire sector.
MTPConnect operates the industry-led Australian Antimicrobial Resistance Network – AAMRNet – a collaborative network of key stakeholders working together to address the impact of AMR on human health. It also has a dedicated Health and Biosecurity team driving development of dual purpose, advanced medical countermeasures and Defence/National Security related technologies.
Across MTPConnect’s accelerator programs, more than $150 million has been directly injected into the Australian life sciences sector, supporting nearly 200 innovation projects. Its investments have leveraged more than $1 billion in additional industry contributions and flow-on external investment, allowing SMEs to scale-up and create new jobs.
MTPConnect’s work has seen more than 1,500 new technologies invented or progressed, 300 new projects launched and over 740,000 patients treated.
MTPConnect is delighted to lead the Australian delegation at BIO2024 in San Diego and work with partners, the state governments of New South Wales, Victoria, Queensland, Western Australia and South Australia, the Department of Industry, Science and Resources, CSIRO and AusBiotech.
As coordinator of the Australian Pavilion at BIO2024, MTPConnect is committed to showcasing Australia’s life sciences excellence as a Global Hub for Advanced Biomanufacturing and Clinical Trials, globally recognised for fast approval processes, world-class infrastructure, strong IP frameworks and generous tax incentives.
Australia has world-leading health and medical research capability in specialist fields such as oncology, neurology, regenerative medicine, infectious diseases, diabetes, cardiovascular disease and diagnostics.
With a strong ecosystem of start-ups through to manufacturing companies, Australia is uniquely positioned to foster innovative, commercial collaborations with international organisations and is increasingly attractive for investment.
With a team of experts across Australia, MTPConnect can leverage its networks and national reach to make international collaborations a reality.
The MTPConnect team looks forward to connecting and introducing you to the world of life sciences opportunity in Australia.
MTPConnect is headquartered in Melbourne, with teams in Adelaide, Perth, Brisbane and Sydney. Tune in to the MTPConnect Podcast Series to connect with the people and the issues behind Australia’s growing life sciences sector. And connect with the team via social media platforms Twitter and LinkedIn or mtpconnect.org.au.
